Literature DB >> 18539272

Inhibition of alpha(4) integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with gambogic acid.

Jie Zhao1, Qi Qi, Yong Yang, Hong-Yan Gu, Na Lu, Wei Liu, Wei Wang, Lei Qiang, Ling-Bo Zhang, Qi-Dong You, Qing-Long Guo.   

Abstract

Gambogic acid, the major active ingredient of gamboge, has been shown to exhibit anti-cancer activity both in vivo and in vitro. However, its potential activity in tumor metastasis remains unclear. In the present study, we found that gambogic acid strongly inhibited the adhesion of highly metastatic mouse melanoma B16-F10 cells in vitro. Gambogic acid also exhibited significant anti-metastasis activity on the development of in vivo artificial metastases (i.e. following tail vein i.v. injection of the B16-F10 melanoma tumor cells in C57BL/6 mice). Flow cytometric analysis and Western blot showed that gambogic acid inhibited the cell surface expression of alpha(4) integrin, while exhibited negligible effects on the expression of alpha(5) and beta(1) integrin. Thus we concluded for the first time that gambogic acid could inhibit the adhesion and migration of B16-F10 cells in vitro and in vivo, in which down-regulation of alpha(4) integrin expression was involved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539272     DOI: 10.1016/j.ejphar.2008.04.063

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  18 in total

Review 1.  Chemistry and biology of the caged Garcinia xanthones.

Authors:  Oraphin Chantarasriwong; Ayse Batova; Warinthorn Chavasiri; Emmanuel A Theodorakis
Journal:  Chemistry       Date:  2010-09-03       Impact factor: 5.236

Review 2.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

3.  Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.

Authors:  Guang-Ming Huang; Yu Sun; Xin Ge; Xin Wan; Chun-Bo Li
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

4.  Molecular pathways: VCAM-1 as a potential therapeutic target in metastasis.

Authors:  Qing Chen; Joan Massagué
Journal:  Clin Cancer Res       Date:  2012-08-09       Impact factor: 12.531

5.  Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

6.  Absolute configuration of (-)-gambogic acid, an antitumor agent.

Authors:  Yulin Ren; Chunhua Yuan; Hee-byung Chai; Yuanqing Ding; Xing-Cong Li; Daneel Ferreira; A Douglas Kinghorn
Journal:  J Nat Prod       Date:  2010-11-10       Impact factor: 4.050

Review 7.  Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi.

Authors:  Buyun Jia; Shanshan Li; Xuerui Hu; Guangyu Zhu; Weidong Chen
Journal:  AAPS PharmSciTech       Date:  2015-07-08       Impact factor: 3.246

8.  Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor.

Authors:  Ju Hye Lee; Mutsumi Kishikawa; Motofumi Kumazoe; Koji Yamada; Hirofumi Tachibana
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

9.  In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction.

Authors:  Peter Gassmann; Mi-Li Kang; Soeren T Mees; Joerg Haier
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

10.  Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis.

Authors:  Qi Qi; Hongyan Gu; Yong Yang; Na Lu; Jie Zhao; Wei Liu; Hua Ling; Qi-dong You; Xiaotang Wang; Qinglong Guo
Journal:  J Mol Med (Berl)       Date:  2008-09-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.